|
SEC
|
Ezickson Elan
|
N/A
|
|
-1.6K
|
$0.54
|
-$864.00
|
|
|
SEC
|
Johnson Marvin
|
N/A
|
|
-1.6K
|
$0.54
|
-$869.40
|
|
|
SEC
|
Braunstein Scott
|
CHAIRMAN AND CEO
|
|
+5.9K
|
$1.10
|
+$6.53K
|
|
|
SEC
|
Braunstein Scott
|
CHAIRMAN AND CEO
|
|
-12K
|
$1.13
|
-$13.72K
|
|
|
SEC
|
Hulihan Joseph
|
CHIEF MEDICAL OFFICER
|
|
-4.8K
|
$1.13
|
-$5.46K
|
|
|
SEC
|
MANNING MARTHA E
|
SVP, GEN. COUNSEL & CORP. SEC.
|
|
-3.6K
|
$1.13
|
-$4.09K
|
|
|
SEC
|
Pfanstiel Steven
|
CFO AND COO
|
|
-4.7K
|
$1.13
|
-$5.26K
|
|
|
SEC
|
Shafer Christina
|
CHIEF COMMERCIAL OFFICER
|
|
-3.8K
|
$1.14
|
-$4.35K
|
|
|
SEC
|
MANNING MARTHA E
|
SVP, GEN. COUNSEL & CORP. SEC.
|
|
-1.9K
|
$9.57
|
-$18.13K
|
|
|
SEC
|
Shafer Christina
|
CHIEF COMMERCIAL OFFICER
|
|
-2.2K
|
$9.56
|
-$20.58K
|
|
|
SEC
|
Braunstein Scott
|
CHAIRMAN AND CEO
|
|
-12K
|
$9.94
|
-$117.79K
|
|
|
SEC
|
Hulihan Joseph
|
CHIEF MEDICAL OFFICER
|
|
-2.8K
|
$9.98
|
-$28.08K
|
|
|
SEC
|
Pfanstiel Steven
|
CFO AND COO
|
|
-3.1K
|
$9.97
|
-$30.83K
|
|
|
SEC
|
Braunstein Scott
|
CHAIRMAN AND CEO
|
|
-6.4K
|
$9.55
|
-$61.53K
|
|
|
SEC
|
Hulihan Joseph
|
CHIEF MEDICAL OFFICER
|
|
-2.9K
|
$9.55
|
-$27.71K
|
|
|
SEC
|
MANNING MARTHA E
|
SVP, GEN. COUNSEL & CORP. SEC.
|
|
-2.2K
|
$9.54
|
-$20.80K
|
|
|
SEC
|
Pfanstiel Steven
|
CFO AND COO
|
|
-2.8K
|
$9.54
|
-$26.75K
|
|
|
SEC
|
Shafer Christina
|
CHIEF COMMERCIAL OFFICER
|
|
-2.4K
|
$9.52
|
-$22.81K
|
|
|
SEC
|
Austin Charles
|
N/A
|
|
-1.1K
|
$6.49
|
-$6.96K
|
|
|
SEC
|
Ezickson Elan
|
N/A
|
|
-750
|
$6.56
|
-$4.92K
|
|
|
SEC
|
Fischer Seth H. Z.
|
N/A
|
|
-1K
|
$6.54
|
-$6.66K
|
|
|
SEC
|
VITULLO NICOLE
|
N/A
|
|
-632K
|
$0.10
|
-$63.24K
|
|
|
SEC
|
Smith Edward F
|
Former VP, CFO & Treasurer
|
|
-4.4K
|
$11.38
|
-$50.40K
|
|
|
SEC
|
Smith Edward F
|
CFO
|
|
-2.4K
|
$2.05
|
-$4.88K
|
|
|
SEC
|
Braunstein Scott
|
Chief Executive Officer
|
|
+100K
|
$1.25
|
+$125.00K
|
|
|
SEC
|
Smith Edward F
|
CFO
|
|
-24K
|
$5.03
|
-$121.78K
|
|
|
SEC
|
Cashman Christopher Michael
|
CEO
|
|
+32K
|
$1.04
|
+$32.93K
|
|
|
SEC
|
Smith Edward F
|
CFO
|
|
-2.5K
|
$3.06
|
-$7.63K
|
|
|
SEC
|
Cashman Christopher Michael
|
CEO
|
|
-8.1K
|
$3.13
|
-$25.48K
|
|
|
SEC
|
Smith Edward F
|
CFO
|
|
-3K
|
$7.91
|
-$23.73K
|
|
|
SEC
|
Cashman Christopher Michael
|
CEO
|
|
-9.6K
|
$6.28
|
-$60.07K
|
|
|
SEC
|
Koppel Adam
|
N/A
|
|
-1.3M
|
$7.88
|
-$10.03M
|
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-751K
|
$1.39
|
-$1.04M
|
|
|
SEC
|
Canaan Partners VII LLC
|
N/A
|
|
-149K
|
$1.50
|
-$223.73K
|
|
|
SEC
|
Canaan Partners VII LLC
|
N/A
|
|
-146K
|
$1.50
|
-$218.37K
|
|
|
SEC
|
Canaan Partners VII LLC
|
N/A
|
|
-25K
|
$1.71
|
-$41.96K
|
|
|
SEC
|
Canaan Partners VII LLC
|
N/A
|
|
-21K
|
$1.81
|
-$37.27K
|
|
|
SEC
|
Canaan Partners VII LLC
|
N/A
|
|
-271K
|
$1.90
|
-$514.43K
|
|
|
SEC
|
Cashman Christopher Michael
|
President and CEO
|
|
+3.6K
|
$5.61
|
+$19.98K
|
|
|
SEC
|
Farfel Gail M
|
Chief Clinical Dev & Reg Offic
|
|
-30K
|
$9.48
|
-$284.40K
|
|
|
SEC
|
Bloch Stephen M
|
N/A
|
|
+625K
|
$8.00
|
+$5.00M
|
|
|
SEC
|
Canaan Partners VII LLC
|
N/A
|
|
+625K
|
$8.00
|
+$5.00M
|
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
+751K
|
$8.00
|
+$6.01M
|
|
|
SEC
|
VITULLO NICOLE
|
N/A
|
|
+420K
|
$8.00
|
+$3.36M
|
|
